Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. SNES
SNES logo

SNES Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
1.690
Open
1.680
VWAP
1.67
Vol
12.71K
Mkt Cap
8.91M
Low
1.651
Amount
21.27K
EV/EBITDA(TTM)
--
Total Shares
5.30M
EV
546.76K
EV/OCF(TTM)
--
P/S(TTM)
2.47
SenesTech, Inc. develops and commercializes products for managing animal pest populations, initially rat populations, through fertility control. The Company’s product lines of fertility control products are: ContraPest, Evolve Rat, and Evolve Mouse. Its product, ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions in the rat population. The Evolve Rat is a soft bait product that contains the active ingredient, cottonseed oil, which reduces fertility in both male and female rats. The Evolve Mouse, a modified version of soft bait technology containing the active ingredient cottonseed oil, which limits reproduction of male and female mice after one to two breeding cycles following consumption.
Show More

Events Timeline

(ET)
2026-03-12
16:20:00
Company Reports Q4 Revenue of $421M, CEO Highlights Significant Progress in 2025
select
2026-02-18 (ET)
2026-02-18
09:00:00
SenesTech Reports Significant Reductions in Rodent Activity
select
2026-01-28 (ET)
2026-01-28
16:30:00
SenesTech CEO Joel Fruendt Announces Retirement
select
2025-11-10 (ET)
2025-11-10
16:24:14
SenesTech announces Q3 earnings per share of 28 cents compared to a loss of $2.07 in the previous year.
select
2025-09-10 (ET)
2025-09-10
08:02:41
SenesTech Announces Availability of Evolve Rat Birth Control Product on HomeDepot.com
select
2025-08-05 (ET)
2025-08-05
08:08:09
SenesTech announces warrant exercise for $6.3M in gross proceeds
select
2025-07-01 (ET)
2025-07-01
08:02:13
SenesTech exercises warrants for $4.4M in gross proceeds
select
2025-06-26 (ET)
2025-06-26
08:04:07
SenesTech's Evolve rodent birth control tested in Hong Kong, San Francisco
select
2025-06-25 (ET)
2025-06-25
08:02:45
SenesTech announces end of field trial of Evolve Rat Birth Control
select

News

seekingalpha
9.5
03-13seekingalpha
SenesTech, Inc. Q4 2025 Earnings Call Insights
  • CEO Transition Management: Following Joel Fruendt's retirement, SenesTech is conducting a formal search for a new CEO, with management emphasizing that the transition is orderly and business operations continue uninterrupted, ensuring strategic stability and effective resource allocation.
  • Significant Revenue Growth: In 2025, SenesTech reported a 20% year-over-year revenue increase to approximately $2.2 million, despite a $200,000 revenue impact in Q4 from the transition to direct Amazon sales, indicating strong market demand overall.
  • Successful E-commerce Strategy: E-commerce revenue surged by 88%, now accounting for over half of total revenue, demonstrating the company's robust performance on Amazon and its direct-to-consumer website, which is expected to further drive future growth.
  • Legal Dispute Resolution: The legal dispute with Liphatech has been resolved satisfactorily, with all litigation dismissed, and management has committed to maintaining communication with shareholders to ensure business stability during the leadership transition.
NASDAQ.COM
2.0
03-12NASDAQ.COM
SenesTech (SNES) Q4 2025 Earnings Call Transcript
PRnewswire
9.5
03-09PRnewswire
SenesTech Schedules Q4 and FY 2025 Financial Results Release
  • Financial Results Announcement: SenesTech is set to release its fourth quarter and fiscal year 2025 financial results after market close on March 12, 2026, reflecting the company's ongoing commitment to financial transparency.
  • Conference Call Timing: On the same day, a conference call will be held at 5:00 p.m. ET to analyze the financial results in depth and engage with investors, thereby enhancing investor relations.
  • Live Webcast Information: Interested parties can access the conference call via a live webcast available in the Investor Relations section of the company's website, ensuring broad dissemination and transparency of information.
  • Replay Availability: A replay of the webcast will be accessible in the Investor Relations section for at least 90 days post-conference, further improving information accessibility and company transparency.
Newsfilter
9.5
03-09Newsfilter
SenesTech Schedules Q4 and FY 2025 Financial Results Release
  • Financial Results Announcement: SenesTech is set to release its financial results for Q4 and FY 2025 after market close on March 12, 2026, reflecting the company's ongoing commitment to managing rodent populations through innovative birth control solutions.
  • Conference Call Timing: On the same day, a conference call will be held at 5:00 p.m. ET to discuss the financial results in detail, aiming to bolster investor confidence in the company's future prospects.
  • Live Webcast Information: Interested parties can access the conference call via a live webcast available in the Investor Relations section of the company's website, ensuring transparency and fostering engagement with investors, thereby enhancing the company's public image.
  • Replay Availability: A replay of the webcast will be accessible in the Investor Relations section for at least 90 days post-conference, allowing investors who could not attend live to obtain critical information, thus improving information accessibility.
PRnewswire
7.5
02-18PRnewswire
SenesTech's Evolve Rodent Birth Control Shows Significant Reduction in Rodent Activity
  • Urban Rodent Management Success: Following the deployment of Evolve® Rodent Birth Control in two urban areas, SenesTech reported significant reductions in rodent activity over a five-month monitoring period, indicating the product's effectiveness in urban environments.
  • Monitoring Data Support: In the first area, where Evolve was deployed starting in April 2025, tracking data from August 2025 to January 2026 showed declines in both rodent presence and activity levels, despite the absence of baseline data, highlighting the product's positive impact.
  • Comparative Trial Results: In the second area, Evolve was deployed immediately after an August 2025 baseline survey, resulting in measurable reductions in rodent activity within five months, based on both presence and density indicators, further validating the product's efficacy.
  • Industry Impact and Outlook: CEO Joel Fruendt emphasized that objective field data is critical for municipalities and pest management professionals evaluating fertility control as part of broader integrated pest management programs, potentially driving future expansions into new locations.
PRnewswire
8.5
02-02PRnewswire
SenesTech Launches Evolve to Support New Zealand's Predator Free 2050 Initiative
  • Product Approval: SenesTech's Evolve has been approved by New Zealand's Ministry for Primary Industries, marking its official launch in the market and is expected to effectively address local rodent issues while enhancing ecological protection efforts.
  • Ecological Protection Strategy: New Zealand plans to invest over NZD 4.5 billion in its Predator Free 2050 initiative, and Evolve, as a non-lethal fertility control solution, will help reduce rodent populations, safeguarding native species and ecosystems.
  • Market Demand Alignment: CEO Joel Fruendt stated that Evolve aligns with New Zealand's increasingly stringent environmental policies and regulatory standards, meeting the urgent market demand for sustainable alternatives to traditional rodenticides, thereby enhancing the company's leadership in high-growth markets.
  • Ongoing Supply Chain: SenesTech has shipped to its exclusive distribution partner Evicom and expects to maintain a regular shipping schedule, ensuring a stable supply of Evolve products and further solidifying its influence in the New Zealand market.
Wall Street analysts forecast SNES stock price to rise
1 Analyst Rating
Wall Street analysts forecast SNES stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
10.00
Averages
10.00
High
10.00
Current: 0.000
sliders
Low
10.00
Averages
10.00
High
10.00
No data

No data

Valuation Metrics

The current forward P/E ratio for Senestech Inc (SNES.O) is 0.00, compared to its 5-year average forward P/E of -1.07. For a more detailed relative valuation and DCF analysis to assess Senestech Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-1.07
Current PE
0.00
Overvalued PE
-0.26
Undervalued PE
-1.88

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-0.55
Current EV/EBITDA
-0.16
Overvalued EV/EBITDA
0.53
Undervalued EV/EBITDA
-1.64

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
4.06
Current PS
1.63
Overvalued PS
9.34
Undervalued PS
-1.22

Financials

AI Analysis
Annual
Quarterly

Whales Holding SNES

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Senestech Inc (SNES) stock price today?

The current price of SNES is 1.68 USD — it has increased 2.44

What is Senestech Inc (SNES)'s business?

SenesTech, Inc. develops and commercializes products for managing animal pest populations, initially rat populations, through fertility control. The Company’s product lines of fertility control products are: ContraPest, Evolve Rat, and Evolve Mouse. Its product, ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions in the rat population. The Evolve Rat is a soft bait product that contains the active ingredient, cottonseed oil, which reduces fertility in both male and female rats. The Evolve Mouse, a modified version of soft bait technology containing the active ingredient cottonseed oil, which limits reproduction of male and female mice after one to two breeding cycles following consumption.

What is the price predicton of SNES Stock?

Wall Street analysts forecast SNES stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SNES is10.00 USD with a low forecast of 10.00 USD and a high forecast of 10.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Senestech Inc (SNES)'s revenue for the last quarter?

Senestech Inc revenue for the last quarter amounts to 421.00K USD, decreased -15.97

What is Senestech Inc (SNES)'s earnings per share (EPS) for the last quarter?

Senestech Inc. EPS for the last quarter amounts to -0.34 USD, decreased -72.13

How many employees does Senestech Inc (SNES). have?

Senestech Inc (SNES) has 23 emplpoyees as of April 03 2026.

What is Senestech Inc (SNES) market cap?

Today SNES has the market capitalization of 8.91M USD.